Pharmafile Logo
Pharmafocus logo
Advanced Search
Sun Pharma logo

Sun Pharma hit by FDA inspection warning

December 22, 2015
Manufacturing and Production FDA, Sun Pharma, manufacturing, production

Sun Pharma shares fell some 7% early this week after it emerged the Indian company received a warning letter from …

News

Former Cubist chief executive Michael Bonney to chair board at Alnylam

December 22, 2015
Manufacturing and Production, Research and Development, Sales and Marketing Alnylam, David Pyott, michael bonney

Michael Bonney, current board member and former chief executive of Cubist Pharmaceuticals, has been appointed as chairman of Alnylam Pharmaceuticals …

Appointment
cdic_bangladesh_dhaka_day_12

Two billion people still lack medicines access. Is the industry doing enough?

December 22, 2015
Manufacturing and Production Access to Medicine Foundation, Access to Medicine Index, affordability, market access, medicines access, pricing

“We have a mission to encourage the pharmaceutical industry in improving access to medicine for the two billion people who …

Feature
sir_kent_woods

EMA management board chair stands down

December 21, 2015
Manufacturing and Production, Sales and Marketing EMA, European Medicines Agency, Sir Kent Woods

Sir Kent Woods will step down as chair of the board at the EMA from the end of December 2015. …

Appointment
Keytruda image

MSD’s Keytruda impresses in lung cancer chemotherapy trial

December 21, 2015
Manufacturing and Production, Research and Development MSD, PD-L1, docetaxel, keytruda, lung cancer, non small cell lung cancer, non-small cell lung cancer, pd-1, pembrolizumab

MSD’s Keytruda significantly improved overall survival (OS) compared to chemotherapy in people with lung cancer and PD-L1 expression, a trial …

News

Novartis completes purchase of rights to GSK drug for up to $1bn

December 21, 2015
Manufacturing and Production, Research and Development, Sales and Marketing

Novartis has completed the acquisition of all outstanding rights to Arzerra from GSK for up to $1.034 billion. The deal, …

News
Pfizer sign

Experts predict pharma sector to remain strong in 2016

December 21, 2015
Sales and Marketing marketing, pharma, profits, sales

The year 2016 is set to see continued growth in research and development productivity, with significant new drug launches and …

News
Ionis logo

ISIS Pharma changes name to Ionis to avoid ‘distracting’ militant association

December 21, 2015
Sales and Marketing Ionis, Isis Pharmaceuticals, branding, marketing, rebrand

After months of discussion, ISIS Pharmaceuticals has changed its name to Ionis to free itself from the fear of confusion …

News
580x381_merck_opens_its_office_in_nigeria_3_tcm2432_145041

Merck on the march in Africa

December 21, 2015
Sales and Marketing Africa, Merck, marketing, sales, strategy

When Merck unveiled its Africa 2020 strategy in November, there was no shortage of ambition.The company announced plans to expand …

Feature
EU flag

Three AstraZeneca drugs recommended by EMA committee

December 21, 2015
Sales and Marketing AstraZeneca, Brilique, CHMP, EMA, Portrazza, Tagrisoo, lesinurad, lilly

The EMA’s Committee for Medicinal Products for Human Use (CHMP) has recommended several new drugs in its latest meeting, including …

News
shkreli_thumb

Martin Shkreli resigns from Turing

December 21, 2015
Sales and Marketing Martin Shkreli, Shkreli, Turing Pharmaceuticals

Following his arrest on securities fraud charges, Martin Shkreli has resigned as chief executive of Turing and been replaced by …

Appointment
paris_alternate_high-res_web

Ariad names EMD Serono’s Paris Panayiotopoulos as new president and chief exec

December 21, 2015
Sales and Marketing Ariad, Ariad Pharmaceuticals, EMD Serono, Paris Panayiotopoulos, harvey Berger

The board of directors at Ariad Pharmaceuticals has appointed Paris Panayiotopoulos as president and chief executive from 1 January 2016. …

Appointment
Gilead sign

Gilead steps in to rescue Galapagos RA drug

December 18, 2015
Sales and Marketing AbbVie, Gilead, Gilead Sciences, filgotinib, inflammation, inflammatory diseases, rheumatoid arthritis

Gilead Sciences is to pay $725million for the rights to filgotinib, a JAK1-selective inhibitor for rheumatoid arthritis and other inflammatory …

News
Imlygic

European approval for Amgen cancer drug Imlygic

December 18, 2015
Sales and Marketing Amgen, European Commission, Imlygic, melanoma, skin cancer, t-vec, talimogene laherparepvec

The European Commission has approved the use of Amgen’s Imlygic for adults with advanced melanoma, making it the first drug …

News
shkreli_youtube_screenshot

Karma may have caught up with Martin Shkreli, but America’s drug pricing problem isn’t about one man

December 18, 2015
Manufacturing and Production, Sales and Marketing Daraprim, Martin Shkreli, Turing Pharmaceuticals

As so often occurs in situations of this kind, Twitter reacted with a significant amount of glee and schadenfreude to …

Feature
ceo_arnaud_lallouette

Servier UK appoints new chief executive

December 18, 2015
Manufacturing and Production, Research and Development, Sales and Marketing Arnaud Lallouette, Mike Sumpter, Servier

Dr Arnaud Lallouette has been appointed chief executive of Servier Laboratories, the UK subsidiary of the French-based pharma firm, after …

Appointment
tim-walbert

Horizon chief exec Walbert to head up US biotech trade body

December 18, 2015
Manufacturing and Production, Research and Development, Sales and Marketing Illinois Biotechnology Industry Organisation, Timothy Walbert, iBio, illinois

Timothy Walbert, the chairman, president and chief executive of Horizon Pharma, has been elected as chairman of the board of …

Appointment
landing-hero-images1

ViiV Healthcare to acquire Bristol-Myers Squibb’s HIV pipeline drugs

December 18, 2015
Medical Communications, Research and Development, Sales and Marketing BMS, Bristol-Myers Squibb, HIV, ViiV, ViiV Healthcare

Specialist HIV company ViiV Healthcare has agreed deals worth up to $1.46 billion to purchase Bristol-Myers Squibb’s late stage HIV …

News
astellas_main_web_2_0

Astellas investigated for ‘misleading’ PMCPA during ABPI code complaint

December 18, 2015
Medical Communications ABPI Code, Astellas, Astellas Pharma Europe, PMCPA, Prescription Medicines Code of Practice Authority

The Prescription Medicines Code of Practice Authority is investigating Astellas for deliberately providing an ‘incomplete and misleading’ response to a …

News

Prime Medical Group expands senior editorial team

December 17, 2015
Medical Communications Prime Medical Group

The Prime Medical Group has announced the appointment of Valerie Moss PhD to the position of editorial & scientific executive …

Appointment
The Gateway to Local Adoption Series

Latest content

Closing the immunisation gap: partnership working that delivered at scale

June 5, 2026

Phase 2 study explores imaging approach for interstitial lung disease

June 5, 2026

Laverock secures funding for gene-control platform development

June 4, 2026

LifeArc and Elpida partner to advance gene therapies for ultra-rare childhood diseases

June 3, 2026

Well Pharmacy and Alzheimer’s Society launch dementia partnership

June 2, 2026